These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6890424)

  • 1. Heparin-released lipolytic activity in the forearm vascular bed in patients with hypertriglyceridaemia.
    Eklund B; Söderberg B
    Clin Physiol; 1982 Oct; 2(5):373-8. PubMed ID: 6890424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K; Avramoglu RK; Sawyez C; Huff MW
    Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in heparin-released lipolytic activity in the superficial and deep veins of the human forearm.
    Heaf DJ; Kaijser L; Eklund B; Carlson LA
    Eur J Clin Invest; 1977 Jun; 7(3):195-9. PubMed ID: 408144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
    Millot F; Bara L; Etienne J; Samama M; Laruelle P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):397-400. PubMed ID: 2837726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
    Evans AJ; Wolfe BM; Strong WL; Huff MW
    Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin.
    Persson E; Nordenström J; Nilsson-Ehle P; Hagenfeldt L
    Eur J Clin Invest; 1985 Aug; 15(4):215-20. PubMed ID: 3930257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
    de Man FH; de Beer F; van der Laarse A; Jansen H; Leuven JA; Souverijn JH; Vroom TF; Schoormans SC; Fruchart JC; Havekes LM; Smelt AH
    Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fasting on two postheparin plasma triglyceride lipases and triglyceride removal in obese subjects.
    Huttunen JK; Ehnholm C; Nikkilä EA; Ohta M
    Eur J Clin Invest; 1975 Nov; 5(6):435-45. PubMed ID: 1201762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced release of lipase activity in the human forearm: an immunological study.
    Ehnholm C; Heaf DJ; Kaijser L; Kinnunen PK; Carlson LA
    Atherosclerosis; 1977 May; 27(1):35-9. PubMed ID: 324491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No vasodilator response to low-dose heparin in the forearm skeletal-muscle vascular bed.
    Abbink EJ; de Galan BE; van Ginneken EE; van Rosendaal AJ; Smits P
    Eur J Clin Pharmacol; 2002 Apr; 58(1):7-10. PubMed ID: 11956666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Shepherd J; Taskinen MR
    Atherosclerosis; 1999 Oct; 146(2):381-90. PubMed ID: 10532694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin-induced lipolytic activity on the structure of rat high-density lipoprotein.
    Swaney JB; Orishimo MW
    Biochim Biophys Acta; 1989 Apr; 1002(3):338-47. PubMed ID: 2713384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal changes in serum triglycerides as related to changes in lipolytic enzymes, lipoproteins and hormones in patients with primary endogenous hypertriglyceridaemia on a carbohydrate-rich diet.
    Mirani-Oostdijk CP; Havekes L; Van Gent CM; Frölich M; Jansen H; Terpstra J
    Atherosclerosis; 1985 Nov; 57(2-3):129-37. PubMed ID: 3910056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total parenteral nutrition with intralipid in premature infants receiving TPN with heparin: effect on plasma lipolytic enzymes, lipids, and glucose.
    Berkow SE; Spear ML; Stahl GE; Gutman A; Polin RA; Pereira GR; Olivecrona T; Hamosh P; Hamosh M
    J Pediatr Gastroenterol Nutr; 1987; 6(4):581-8. PubMed ID: 3123635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprandial systemic and regional lipase activity in normal humans.
    Coppack SW; Yost TJ; Fisher RM; Eckel RH; Miles JM
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E718-22. PubMed ID: 8928780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type IV hyperlipoproteinemia in patients with algodystrophy.
    Guenee B; Tallet F; Raichvarg D; Ekindjian OG; Kharrat A; de Gery A; Amor B
    Clin Exp Rheumatol; 1985; 3(1):49-52. PubMed ID: 3978893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.